Product Information
COLACE 2-IN-1 TABLET is a brand product labeled by Atlantis Consumer Healthcare, Inc., priced at $0.4120 per EA under NDC 67618011010. Its NADAC has been published 472 times since Sep 20, 2017.
Strength
50; 8.6 mg/1; mg/1
Manufacturer
Atlantis Consumer Healthcare, Inc.NDC
67618011010
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOCUSATE SODIUM; SENNOSIDESApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
2/8/1957
Price Statistics
The NADAC for COLACE 2-IN-1 TABLET has been published 472 times since Sep 20, 2017, and over the history we have for it it has declined 4.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4120 per EA |
|---|---|
| All-time high | $0.4860 (Dec 13, 2023) |
| All-time low | $0.3700 (Jan 22, 2020) |
| 52-week high | $0.4182 |
| 52-week low | $0.4120 |
| Median price | $0.4114 |
| Average price | $0.4120 |
| Largest weekly change | +20.1% (Nov 22, 2023) |
| Weeks tracked | 472 |
| Tracking since | Sep 20, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Atlantis Consumer Healthcare, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Docusate sodium - sennosides market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COLACE 2-IN-1 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COLACE 2-IN-1 TABLET, manufactured by Atlantis Consumer Healthcare, Inc., is $0.4120 per EA (NDC 67618011010), effective Sep 30, 2026.
How has the price of COLACE 2-IN-1 TABLET changed over time?
Over the history we have for it, the NADAC for COLACE 2-IN-1 TABLET has declined 4.0%. It has been tracked across 472 weekly CMS publications since Sep 20, 2017.
What are the highest and lowest recorded NADAC prices for COLACE 2-IN-1 TABLET?
Since Sep 20, 2017, the NADAC for COLACE 2-IN-1 TABLET has ranged from a low of $0.3700 (Jan 22, 2020) to a high of $0.4860 (Dec 13, 2023), with a median of $0.4114 per EA.
Are there cheaper alternatives to COLACE 2-IN-1 TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as COLACE 2-IN-1 TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures COLACE 2-IN-1 TABLET?
COLACE 2-IN-1 TABLET (NDC 67618011010) is labeled by Atlantis Consumer Healthcare, Inc., and CMS classifies it as a brand product.